AI 检索
AI 阅读
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

2022-RA-1263-ESGO Phase II randomized BGOG-CX3 trial comparing atezolizumab in combination with doxorubicin versus doxorubicin alone in second-line or later recurrent cervical cancer

Liselore Loverix,Rawand Salihi,Anne-Sophie van Rompuy,Adriaan Vanderstichele,Els van Nieuwenhuysen,Thaïs Baert,Philip Debruyne, Nathalie Cornez,Stéphanie Henry,Patrick Neven,Sileny Han,Patrick Berteloot,Siel Olbrecht,Tina Laga,Pieter Busschaert,Toon van Gorp,Ignace Vergote

Cervical cancer（2022）

引用 0|浏览3
暂无评分
关键词
doxorubicin,atezolizumab,cancer,second-line
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要